Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,077Revenue $M302Net Margin (%)-8.3Z-Score4.5
Enterprise Value $M1,040EPS $-0.4Operating Margin %-7.7F-Score3
P/E(ttm))0Cash Flow Per Share $0.0Pre-tax Margin (%)-8.0Higher ROA y-yN
Price/Book5.710-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %0Current Ratio2.9Lower Leverage y-yN
Price/Cash Flow364y-y EBITDA Growth Rate %-53.3ROA % (ttm)-7.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-12.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M62.0ROI % (ttm)-7.0Gross Margin Increase y-yY

Gurus Latest Trades with NXTM

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NXTMJohn Burbank 2012-12-31 Sold Out -0.09%$10.61 - $13.73
($11.63)
$ 17.1848%Sold Out0
NXTMJohn Burbank 2012-09-30 Buy 0.09%$12.47 - $17.04
($14.28)
$ 17.1820%New holding, 150000 sh.150,000
NXTMRon Baron 2012-06-30 Sold Out -0.02%$14.94 - $19.44
($16.42)
$ 17.185%Sold Out0
NXTMRon Baron 2012-03-31 Buy 0.02%$16.55 - $21.54
($17.89)
$ 17.18-4%New holding, 176418 sh.176,418
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NXTM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NXTM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Turk Joseph E JrPresident 2015-02-25Sell2,082$17.88-5.09view
Swan Winifred LSVP and General Counsel 2015-02-18Sell500$17.6-3.58view
Turk Joseph E JrPresident 2015-02-11Sell1,500$17.56-3.36view
Turk Joseph E JrPresident 2015-01-27Sell2,350$18.7-9.25view
Swan Winifred LSVP and General Counsel 2014-12-29Sell667$18.17-6.6view
Turk Joseph E JrPresident 2014-12-23Sell2,350$18.44-7.97view
Swan Winifred LSVP and General Counsel 2014-12-22Sell667$18.61-8.81view
Swan Winifred LSVP and General Counsel 2014-12-18Sell500$18.25-7.01view
Turk Joseph E JrPresident 2014-12-15Sell2,000$17.45-2.75view
Hershberger KevinChief Accounting Officer 2014-12-15Sell8,000$17.19-1.28view

Press Releases about NXTM :

    Quarterly/Annual Reports about NXTM:

    News about NXTM:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlights: MFLX, NXTM, CVRR, CMLP Nov 10 2013 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Mar 18 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Mar 18 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Feb 18 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Feb 18 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 20,000 Shares Jan 21 2011 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 15,000 Shares Jan 20 2011 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 13,710 Shares Dec 17 2010 
    NxStage Medical Inc. (NXTM) Sr. Vice President, CFO Robert S. Brown sells 12,000 Shares Dec 16 2010 
    NxStage Medical Inc. (NXTM) President & CEO Jeffrey H Burbank sells 13,710 Shares Dec 16 2010 


    More From Other Websites
    NxStage to Present at the Barclays Capital Global Healthcare Conference Mar 04 2015
    NxStage Medical (NXTM) Q4 Loss Narrower than Expected - Analyst Blog Mar 04 2015
    10-K for NxStage Medical, Inc. Feb 28 2015
    NxStage Reports Record Fourth Quarter and Full-Year 2014 Revenue Feb 26 2015
    NxStage Medical Inc Earnings Call scheduled for 9:00 am ET today Feb 26 2015
    NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 26 2015
    NxStage Reports Record Fourth Quarter and Full-Year 2014 Revenue Feb 26 2015
    Q4 2014 NxStage Medical Inc Earnings Release - Before Market Open Feb 26 2015
    NxStage opens first two kidney care centers in Massachusetts Feb 25 2015
    NxStage Kidney Care Brings Flexible Therapy Options To Greater Boston Area Feb 25 2015
    NxStage Kidney Care Brings Flexible Therapy Options To Greater Boston Area Feb 25 2015
    Medtronic's Pipeline Flex Embolization Device Gets FDA Nod - Analyst Blog Feb 09 2015
    NxStage Hosts Panel Discussion on Home Nocturnal Hemodialysis at 2015 Annual Dialysis Conference Feb 02 2015
    NxStage Hosts Panel Discussion on Home Nocturnal Hemodialysis at 2015 Annual Dialysis Conference Feb 02 2015
    Abaxis (ABAX) Beats Q3 Earnings, Revenues; Margin Grows - Analyst Blog Jan 30 2015
    Baxter (BAX) Beats Q4 Earnings Estimates, Sales Up Y/Y - Analyst Blog Jan 29 2015
    Mead Johnson's US Expansion Drives Q4 Earnings Beat - Analyst Blog Jan 29 2015
    St. Jude Q4 Earnings Meet Estimates on Modest Sales Growth - Analyst Blog Jan 28 2015
    NxStage® to Report Fourth Quarter and Full Year 2014 Financial Results Jan 28 2015
    Stryker Lags Q4 Earnings, Revenue Estimates - Analyst Blog Jan 28 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK